Overview

Clinical Study Evaluating the Safety and Efficacy of Roflumilast in Type 2 Diabetic Patients With Diabetic Neuropathy

Status:
Not yet recruiting

Trial end date:
2022-06-10

Target enrollment:

Participant gender:

Summary

Evaluation of the side effects and efficacy of roflumilast on glycemic parameters, insulin resistance, oxidative and inflammatory markers in Type 2 diabetic patients with diabetic neuropathy.

Phase:

Phase 3

Details

Lead Sponsor:

Tanta University

Treatments:

Thioctic Acid